These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21436412)

  • 1. Devastation in Japan. Candidate radiation drugs inch forward.
    Bhattacharjee Y
    Science; 2011 Mar; 331(6024):1505. PubMed ID: 21436412
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Modulation of radiation injury.
    Coleman CN; Stone HB; Moulder JE; Pellmar TC
    Science; 2004 Apr; 304(5671):693-4. PubMed ID: 15118152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of skin injuries with cygerol ointment in radiation therapy].
    Noskov AG
    Med Radiol (Mosk); 1967 Mar; 12(3):55-8. PubMed ID: 5620462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern possibilities of medicinal prophylaxis and early therapy of radiation injuries].
    Grebeniuk AN; Zatsepin VV; Nazarov VB; Vlasenko TN
    Voen Med Zh; 2011 Feb; 332(2):13-7. PubMed ID: 21770338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.
    Singh VK; Romaine PL; Seed TM
    Health Phys; 2015 Jun; 108(6):607-30. PubMed ID: 25905522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status.
    Singh VK; Garcia M; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):870-884. PubMed ID: 28657406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targets of potential radioprotective drugs.
    Hauer-Jensen M; Kumar KS
    Curr Drug Targets; 2010 Nov; 11(11):1351. PubMed ID: 20583983
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with 'standard of care' medicinal and procedures not requiring regulatory approval for use.
    Singh VK; Hanlon BK; Santiago PT; Seed TM
    Int J Radiat Biol; 2017 Sep; 93(9):885-906. PubMed ID: 28657400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of radiation damages (author's transl)].
    Antoku S
    Fukuoka Igaku Zasshi; 1982 Feb; 73(2):71-5. PubMed ID: 7095724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the medical prevention of non-ionizing radiation injury].
    Xue L; Wang SM; Peng RY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Mar; 30(3):233-5. PubMed ID: 22804899
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current status of biological and chemical radiation protection research].
    Langendorff H
    Strahlenschutz Forsch Prax; 1971; 11():90-6. PubMed ID: 4936323
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential utility of peptides against damage induced by ionizing radiation.
    Shaghaghi Z; Alvandi M; Nosrati S; Hadei SK
    Future Oncol; 2021 Apr; 17(10):1219-1235. PubMed ID: 33593084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primperan, a new drug for treatment of gastrointestinal symptoms fo radiation sickness].
    Fochem K
    Ther Ggw; 1969 Mar; 108(3):418 passim. PubMed ID: 4890493
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of radioprotectors on treatment efficacy in combined radiation lesions (a review of the literature)].
    Farshatov MN
    Voen Med Zh; 1986 Jul; (7):22-5. PubMed ID: 3529614
    [No Abstract]   [Full Text] [Related]  

  • 15. [The outlook for the development of drugs for preserving the combat readiness of those with minor injuries from ionizing radiation (a review of the literature)].
    Legeza VI; Abdul' IuA; Boĭko VN
    Voen Med Zh; 1993 Sep; (9):31-3. PubMed ID: 8236896
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory watch: FDA guidance on co-developing investigational drugs.
    Nat Rev Drug Discov; 2011 Feb; 10(2):86. PubMed ID: 21283094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protective effect of Radix Salvia Miltiorrhizae on radiation damage of the cochlea].
    Yang X; Lu Y; Xie D
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):465-7. PubMed ID: 12080686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on biological radiation protection. 90. Radiation sensitivity of the mouse following pre-irradiation as well as following additional administration of radiation-resistance-increasing substances].
    Langendorff H; Langendorff M; Mönig H
    Strahlentherapie; 1970 Mar; 139(3):336-46. PubMed ID: 5506845
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to "Radiation therapeutic gain and Asian botanicals," by Stephen Sagar.
    Lawenda BD
    Integr Cancer Ther; 2010 Mar; 9(1):14-5. PubMed ID: 20308083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podophyllum hexandrum prevents radiation-induced neuronal damage in postnatal rats exposed in utero.
    Sajikumar S; Goel HC
    Phytother Res; 2003 Aug; 17(7):761-6. PubMed ID: 12916074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.